SkinHealth Systems Inc. Cash and Cash Equivalents
SkinHealth Systems Inc. (SKIN) had Cash and Cash Equivalents of $523.02 million as of 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2024-03-12
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $523.02M.
- 2023-09-30: Cash and Cash Equivalents, at Carrying Value $559.44M.
- 2023-06-30: Cash and Cash Equivalents, at Carrying Value $549.73M.
- 2023-03-31: Cash and Cash Equivalents, at Carrying Value $532.28M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2023-12-31 | $523.02M 10-K · filed 2024-03-12 | |
| 2023-09-30 | $559.44M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $549.73M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $532.28M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $568.20M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $684.21M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $820.97M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $859.24M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $901.89M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $718.62M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $101.47M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $2.75M 10-Q · filed 2021-07-01 | |
| 2020-12-31 | $9.49M 10-K · filed 2022-03-01 | $3.27M 10-K · filed 2021-03-18 |
| 2020-09-30 | $25.00K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |